AVBC vs INV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health scores paint a concerning picture, with a Piotroski F-Score of just 1/9 indicating severe financial weakness. Despite strong year-over-year revenue growth of 28%, the company is unprofitable with negative profit and operating margins, undermining its financial stability. Valuation metrics like a Price/Book of 0.93 suggest the market is pricing in limited confidence, while the technical trend score of 10/100 reflects strong bearish momentum. The absence of Altman Z-Score data is a red flag, but the extremely low Piotroski score alone warrants significant caution.
The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. While revenue growth is robust at 80.30%, the valuation is disconnected from reality with a Price/Sales ratio of 169.02 and a catastrophic operating margin of -3859.12%. Despite a 'strong_buy' analyst consensus from a very small sample, heavy insider selling of $10.16M and a bearish technical trend suggest a high-risk speculative environment.
Compare Another Pair
Related Comparisons
AVBC vs INV: Head-to-Head Comparison
This page compares Avidia Bancorp, Inc. (AVBC) and Innventure, Inc. (INV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.